Form 4: VSEE Director Lowdermilk Discloses Future Equity Compensation

VSEE Health Director Kevin Lowdermilk has disclosed the anticipated acquisition of 68,624 shares of common stock through the company's 2024 Incentive Plan as future compensation for services.

Summary

• Kevin Lowdermilk, a Director of VSEE Health, Inc., is expected to acquire a total of 68,624 shares of common stock.
• These acquisitions are anticipated to occur on September 19, 2025, and represent compensation for services as a non-employee director.
• The shares are to be issued under the company's 2024 Incentive Plan.
• The compensation covers services for quarters ending June 30, 2024, September 30, 2024, December 31, 2024, March 31, 2025, June 30, 2025, and September 30, 2025.
• The number of shares for each period was determined by the closing price of the common stock on specific dates ranging from September 30, 2024, to September 22, 2025.
• The anticipated acquisition prices range from $0.69 to $2.31 per share.
• Following these anticipated transactions, Kevin Lowdermilk is expected to directly beneficially own 68,624 shares of VSEE common stock.

Sentiment

Score: 5

Explanation: The filing discloses future equity compensation for a director, which is a neutral event in itself as it's part of a compensation plan. The declining trend in the anticipated share prices for compensation over the periods covered could be a slight negative signal regarding future stock valuation, but this is offset by the alignment of director and shareholder interests through equity compensation.

Positives

• The company has a structured plan (2024 Incentive Plan) to compensate non-employee directors with equity, which aligns their interests with shareholders.
• The anticipated acquisition of 68,624 shares by a director indicates a planned increase in insider ownership.

Negatives

• The anticipated share prices at which the compensation shares were valued show a declining trend from $2.31 (for Q2 2024 services) down to $0.69 (for Q3 2025 services), which could reflect a projected decrease in the company's stock valuation over the periods covered.

Risks

• NA

Future Outlook

This filing outlines planned equity compensation for a director for services rendered across several future quarters, indicating the company's ongoing use of its 2024 Incentive Plan for non-employee director remuneration.

Industry Context

This Form 4 filing is specific to VSEE Health, Inc. and its director's anticipated compensation, and does not provide broader industry context or trends.

Corporate Governance

Related Party Transactions

• The anticipated acquisition of common stock by Kevin Lowdermilk, a director of VSEE Health, Inc., as compensation for services, constitutes a related party transaction.

Stakeholder Impact

• Shareholders: Increased director ownership may be viewed positively as it aligns management interests with shareholder value. The declining trend in the anticipated share price at which compensation was valued over time could be a concern for existing shareholders.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Key Dates

Keywords

VSEE Health, Kevin Lowdermilk, Director Compensation, Insider Ownership, Stock Acquisition, Form 4, SEC Filing, Equity Incentive Plan, Beneficial Ownership